Yoneshima Y, Kato K, Minami H, Ikeda M, Watanabe H, Yoshimoto G, Miyamoto T, Akashi K, Nakanishi Y, Okamoto I
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors
Cancer Sci
2020年9月111(9):3395-3396
Shigematsu T, Suetsugu K, Yamamoto N, Tsuchiya Y, Masuda S
Comparison of 4 commercial immunoassays used in measuring the concentration of tacrolimus in blood and their cross-reactivity to its metabolites
Ther Drug Monit
2020年6月42(3):400-406
Matsukane R, Watanabe H, Minami H, Hata K, Suetsugu K, Tsuji T, Masuda S, Okamoto I, Nakagawa T, Ito T, Eto M, Mori M, Nakanishi Y, Egashira N
Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events
Sci Rep
2021年 1月第11巻(1)1324
Sasaki K, Tsuji T, Kimoto Y, Yanagihara Y, Masuguchi K, Chikamori A, Watanabe H, Murakami T, Oryoji D, Hashimoto M, Horiuchi T, Egashira N
Usefulness of daily folic acid supplementation during methotrexate treatment of Japanese patients with rheumatoid arthritis
Mod Rheumatol
2021年1月第31巻(1)108-113
Hata K, Suetsugu K, Egashira N, Makihara Y, Itoh S, Yoshizumi T, Tanaka M, Kohjima M, Watanabe H, Masuda S, Ieiri I
Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
Cancer Chemother Pharmacol
2020年12月86巻(6)803-813
Ishida S, Makihara Y, Watanabe H, Nakashima T, Nagata K, Suetsugu K, Tsuji T, Hata K, Ikeda M, Ikebe M, Minami H, Watanabe H, Nakata K, Nakamura M, Egashira N, Ieiri I
Risk factors for gemcitabine-induced vascular pain in patients with pancreatic cancer